Full Year 2024 MBB SE Earnings Call Transcript

Mar 31, 2025 / 01:00 PM GMT

Transcript

Key Points

Positve

MBB SE (XTER:MBB) achieved a record revenue of over €1 billion in 2024, marking a significant milestone for the company.
The company reported an impressive 86% growth in EBITA, reaching €149 million, which is a substantial increase from the previous year.
MBB SE (XTER:MBB) achieved a record net cash position of over €550 million, demonstrating strong financial health.
The company's subsidiaries, such as For Work and Alman, delivered strong results, contributing to the overall success of MBB SE (XTER:MBB).
MBB SE (XTER:MBB) has a robust balance sheet with a 65% equity ratio, providing a solid foundation for future growth and investments.

Negative

The automotive industry weakness is expected to lead to lower revenue for Aman, one of MBB SE (XTER:MBB)'s subsidiaries, in 2025.
Economic uncertainties, including potential trade wars, pose risks to the company's EBITA margin, which is forecasted to range between 11% and 14% in 2025.
DTS experienced project postponements in 2024 due to hesitance by German SMEs to invest, impacting its performance.
Den faced lower demand in 2024, particularly in the caravan business, resulting in a revenue decline to €65 million.
Cpo had a muted year in 2024, with cautious signs of improvement expected only in 2025.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

MBBG.DE - MBB SE
Full Year 2024 MBB SE Earnings Call
Mar 31, 2025 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Warm welcome ladies and gentlemen, to today's earnings call of the MDBSE following the publication of the financial year figures of 2024.

I'm delighted to welcome CEO Doctor Konstantin Wang and CIO Tom Titler. So the gentlemen will guide us through the presentation and the results shortly. And as always, following the presentation, we will move on to our Q&A session in which you will be allowed to place your questions directly to them. So, having said this, Dr. Manu, I hand over to you.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you and good afternoon. My name is Konstantin

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.